FindTrial
Sign In

Study to Evaluate Whether a 3-Month Ayurvedic Treatment (CDC Therapy) Can Reduce Heart Problems in Patients with Type 2 Diabetes Over One Year.

Comparative study of Major Adverse Cardiovascular Events (MACE) in Patients with Type 2 Diabetes: A Retrospective Cohort Study with 3-Month Add-On Ayurveda Regime (CDC Therapy) versus Standard Care over One Year. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108120
Enrollment
245
Registered
2026-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr Pravin Jayram Ghadigaonkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with T2DM Completed Three Month of 3-Month Add-On Ayurveda Regime Age between 30-70 years.

Exclusion criteria

Exclusion criteria: Incomplete medical records. Concurrent participation in other interventional studies. Post-myocardial infarction (MI). Post-percutaneous transluminal coronary angioplasty (PTCA).

Design outcomes

Primary

MeasureTime frame
Incidence of Major Adverse Cardiovascular Events (MACE) within 1 yearTimepoint: Assessed at 1 year (12 months) after initiation of treatment/exposure—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Chandrakant Bhagwat Chavan

VRTs Madhavbaug Institute of Preventive Cardiology

cbchavan19740210@yahoo.com9823503077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026